The establishment of Pacemaker cell line from human amnion delivered cells, and development of the new pacing therapy
| Project/Area Number |
20390366
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Thoracic surgery
|
|---|
| Research Institution | University of Toyama |
|---|
Principal Investigator |
MISAKI Takurou University of Toyama, 名誉教授 (40092811)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NIKAIDOU Toshio 富山大学, 大学院・医学薬学研究部(医学), 教授 (50180568)
深原 一晃 富山大学, 医学薬学研究部(医), 講師 (40343181)
柳 堅徳 富山大学, 付属病院集中治療部, 助教 (60447654)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
FUKAHARA Kazuaki 富山大学, 大学院・医学薬学研究部(医学), 講師 (40343181)
|
|---|
| Project Period (FY) |
2008 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
Fiscal Year 2010: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2009: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
Fiscal Year 2008: ¥3,120,000 (Direct Cost: ¥2,400,000、Indirect Cost: ¥720,000)
|
|---|
| Keywords | 心臓大血管外科学 |
|---|
| Research Abstract |
In order to perform pacemaker cell replacement therapy using amnion delivered cells as a new therapy instead of the mechanical pacemaker implantation, we developed some methods that to purify Nanog positive cells from Human amnion delivered cells, and gene transfection of Oct4 into Human amnion delivered cells to activate into undifferentiated state. In both methods, more high rate and highly differentiated cardiomyocyte-like cells were observed. These cells showed some structures that are essential to perform as a pacemaker, ion channels that associate with automaticity, and Connexin which forms Gap junction making action potential propagate. We have showed the possibility of the pacemaker cells establishment using Human amniotic delivered cells.
|
Report
(4 results)
Research Products
(5 results)
